Novel drug golexanolone shows promise against cognitive decline in hepatic encephalopathy
Golexanolone, a novel, small molecule, GABA-A receptor-modulating steroid antagonist, helps ease cognitive problems in patients with covert hepatic encephalopathy with no alarming safety signals, a recent study has found.